Reformulated Valproic Acid through CSF Infusion Pump
PRECLINICAL
PHASE 1
PHASE 2
PHASE 3
PRE
P1
P2
P3
Pipeline Type
New Formulations and Indications
Phase Of Development
Phase 2
Sponsors and Collaborators
Cerebral Therapeutics, EF
Mechanism of Action
Mechanism Description
Implantable, programmable drug delivery pump for ICV delivery of Valproate
Populations Tested In
Drug resistant seizures
Other Resources
Special FDA Designation
Nonprofit or Government Support
Nonprofit
Nonprofit or Government Support Description
Epilepsy Foundation- Investment
Previous Presentations
Presented at meetings (latest date) (Pipeline, AEDD; AES, Eilat, etc)
N/A
Location of Clinical Trials
N/A
Clinical Trial link